Cargando…

Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study

OBJECTIVE: To compare three commonly used low-molecular-weight heparins (LWMHs) in the treatment of recurrent spontaneous abortion (RSA) by evaluating the anti-Xa peak levels and adverse reactions. METHODS: In this single-center, observational study, we enrolled 310 patients with RSA in whom anti-Xa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Wenxin, Zhang, Xinyang, Sun, Si, Wang, Qiaohong, Li, Congcong, Zhang, Xiaoxin, Zhao, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495441/ https://www.ncbi.nlm.nih.gov/pubmed/34620101 http://dx.doi.org/10.1186/s12884-021-04161-1

Ejemplares similares

Management of heparin resistance due to antithrombin deficiency in a Chinese pregnant woman: a case report
por: Zhang, Xiaoxin, et al.
Publicado: (2021)

Intracellular Lipid Accumulation Drives the Differentiation of Decidual Polymorphonuclear Myeloid-Derived Suppressor Cells via Arachidonic Acid Metabolism
por: Wang, Qiaohong, et al.
Publicado: (2022)

Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin
por: McDonald, E, et al.
Publicado: (2003)

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
por: Xu, Lengnan, et al.
Publicado: (2023)

Role of low-molecular-weight heparin in altering uterine artery blood flow in recurrent spontaneous abortion: a prospective study
por: Zhang, Kemei, et al.
Publicado: (2020)

Dosage reduction of low weight heparin in patients with renal dysfunction: Effects on anti-Xa levels and clinical outcomes
por: Hornung, Paul, et al.
Publicado: (2020)

Clinical Impact of Nurses-Physicians Collaboration Intervention on the Treatment of Immune Recurrent Spontaneous Abortion with Low-Molecular-Weight Heparin
por: Chen, Miaocheng, et al.
Publicado: (2021)

Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy
por: Byun, Jung-Hyun, et al.
Publicado: (2016)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Chinese traditional herbs enhanced the clinical efficacy of low-molecular-weight heparin in the treatment of recurrent spontaneous abortion complicated with thrombophilia
por: Tian, Ye, et al.
Publicado: (2023)

Retracted: Clinical Impact of Nurses-Physicians Collaboration Intervention on the Treatment of Immune Recurrent Spontaneous Abortion with Low-Molecular-Weight Heparin
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
por: Li, Congcong, et al.
Publicado: (2020)

Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition
por: Rashid, Qudsia, et al.
Publicado: (2014)

Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy
por: McLaughlin, Kevin, et al.
Publicado: (2019)

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
por: Taleja, Hitesh, et al.
Publicado: (2021)

Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia
por: Chan, Meng, et al.
Publicado: (2021)

Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays
por: Thomas, Owain, et al.
Publicado: (2015)

Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients
por: Brakta, Charlyne, et al.
Publicado: (2023)

Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms
por: Whitman-Purves, Emily, et al.
Publicado: (2017)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
por: Nguyen, Tung Phi, et al.
Publicado: (2021)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
por: Nguyen, Lily, et al.
Publicado: (2023)

Effect of low dose aspirin application during pregnancy on fetal congenital anomalies
por: Sun, Si, et al.
Publicado: (2022)

Adverse Pregnancy Outcomes of Patients with History of First-Trimester Recurrent Spontaneous Abortion
por: Yang, Jing, et al.
Publicado: (2017)

Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis
por: Yu, Xiaomei, et al.
Publicado: (2021)

Abortion; Spontaneous and Induced
por: Winfrey, J. A.
Publicado: (1900)

Low molecular weight heparin monotherapy for recurrent abortion with antiphospholipid system: A protocol of a systematic review
por: Ni, Lei, et al.
Publicado: (2019)

Full trisomy 5 in a sample of spontaneous abortion and arias stella reaction
por: Čulić, Vida, et al.
Publicado: (2011)

An XA21-Associated Kinase (OsSERK2) Regulates Immunity Mediated by the XA21 and XA3 Immune Receptors
por: Chen, Xuewei, et al.
Publicado: (2014)

Xa tantlin lisantiago /
por: Ibarra, José Xochihua
Publicado: (1993)

Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions
por: Riahi, Nada, et al.
Publicado: (2023)

Peak Vertical Ground Reaction Force during Two-Leg Landing: A Systematic Review and Mathematical Modeling
por: Niu, Wenxin, et al.
Publicado: (2014)

Reproductive Factors and Risk of Spontaneous Abortion in the Jinchang Cohort
por: Hu, Xiaobin, et al.
Publicado: (2018)

Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways
por: Zhang, Qian, et al.
Publicado: (2023)

Corrigendum to “Peak Vertical Ground Reaction Force during Two-Leg Landing: A Systematic Review and Mathematical Modeling”
por: Niu, Wenxin, et al.
Publicado: (2015)

Adverse Drug Reactions of Spontaneous Reports in Shanghai Pediatric Population
por: Li, Hui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_on8k4udh6rlu8vvdhoov2kt3nk